Pharmaceutical Benefits Advisory Committee: some questions answered.
Bandouvakis
J
J
D000730:Androstadienes / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001315:Australia; D000068298:Fluticasone; D005569:Formularies as Topic; D006801:Humans; D007356:Insurance, Pharmaceutical Services
D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D000068298:Fluticasone